Epharmix works with leading physicians and independent researchers to generate clinical outcomes and publishes evidence for Epharmix technology. The Epharmix Research Center has achieved seven peer-reviewed journal publications and over two dozen conference acceptances to-date.
Epharmix Research Center
Chief Medical Officer
Clinical Research Specialist
Washington University School of Medicine in St. Louis
From Phase II to Phase IV research, every Epharmix intervention must meet several critera. Fewer than 20% of intervention proposals make it past these phases.
The Epharmix Research Center is open to opportunities to inform people of our best practices.
Learn how providers in a resident clinic setting at a top academic institution reduced hospitalization risk with Epharmix.
See how care management at a large health system used Epharmix to quickly get patients with diabetes to control.
Patients in community and rural health system settings maintain high annual engagement on Epharmix.